MoneyWorks4Me

Marksans Pharma - Quaterly Results

30 May 2022 Evaluate
The sales for the March 2022 quarter moved up 28.12% to Rs. 1762.78 millions as compared to Rs. 1375.83 millions during the corresponding quarter last year.The Company's Net profit for the March 2022 quarter have declined marginally to Rs. 214.27  millions as against Rs. 236.88 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 345.16 millions from 386.87 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1762.78 1375.83 28.12 6582.89 5995.48 9.80 6582.89 5995.48 9.80
Other Income 76.48 119.08 -35.77 422.51 311.56 35.61 422.51 311.56 35.61
PBIDT 345.16 386.87 -10.78 1559.66 1448.68 7.66 1559.66 1448.68 7.66
Interest 12.78 21.38 -40.22 37.95 53.45 -29.00 37.95 53.45 -29.00
PBDT 332.38 365.49 -9.06 1521.71 1395.23 9.07 1521.71 1395.23 9.07
Depreciation 46.08 41.45 11.17 176.63 151.93 16.26 176.63 151.93 16.26
PBT 286.30 324.04 -11.65 1345.08 1243.30 8.19 1345.08 1243.30 8.19
TAX 72.03 87.16 -17.36 305.20 259.49 17.62 305.20 259.49 17.62
Deferred Tax -11.26 10.58 -206.43 5.04 -22.39 -122.51 5.04 -22.39 -122.51
PAT 214.27 236.88 -9.54 1039.88 983.81 5.70 1039.88 983.81 5.70
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 19.58 28.12 -30.37 23.69 24.16 -1.95 23.69 24.16 -1.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..